Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $396.40 million. The enterprise value is $419.37 million.
Important Dates
The next confirmed earnings date is Tuesday, November 12, 2024, after market close.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 132.58 million shares outstanding. The number of shares has decreased by -0.40% in one year.
| Current Share Class | 132.58M |
| Shares Outstanding | 132.58M |
| Shares Change (YoY) | -0.40% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 37.84% |
| Owned by Institutions (%) | 37.62% |
| Float | 59.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 299.00 |
| PS Ratio | 0.88 |
| Forward PS | 0.84 |
| PB Ratio | 1.50 |
| P/FCF Ratio | 46.53 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.97, with an EV/FCF ratio of 49.23.
| EV / Earnings | n/a |
| EV / Sales | 0.94 |
| EV / EBITDA | 13.97 |
| EV / EBIT | 30.27 |
| EV / FCF | 49.23 |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.43.
| Current Ratio | 2.73 |
| Quick Ratio | 2.28 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 2.42 |
| Debt / FCF | 13.25 |
| Interest Coverage | 6.66 |
Financial Efficiency
Return on equity (ROE) is -6.19% and return on invested capital (ROIC) is 2.24%.
| Return on Equity (ROE) | -6.19% |
| Return on Assets (ROA) | 1.94% |
| Return on Capital (ROIC) | 2.24% |
| Revenue Per Employee | $520,176 |
| Profits Per Employee | -$19,194 |
| Employee Count | 862 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 4.27 |
Taxes
In the past 12 months, ORGO has paid $3.50 million in taxes.
| Income Tax | 3.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.16% in the last 52 weeks. The beta is 1.60, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +26.16% |
| 50-Day Moving Average | 2.89 |
| 200-Day Moving Average | 2.89 |
| Relative Strength Index (RSI) | 52.50 |
| Average Volume (20 Days) | 437,579 |
Short Selling Information
The latest short interest is 10.30 million, so 7.77% of the outstanding shares have been sold short.
| Short Interest | 10.30M |
| Short Previous Month | 10.44M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 17.23% |
| Short Ratio (days to cover) | 22.83 |
Income Statement
In the last 12 months, ORGO had revenue of $448.39 million and -$16.55 million in losses. Loss per share was -$0.13.
| Revenue | 448.39M |
| Gross Profit | 336.94M |
| Operating Income | 13.85M |
| Pretax Income | -13.04M |
| Net Income | -16.55M |
| EBITDA | 30.01M |
| EBIT | 13.85M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $89.90 million in cash and $112.87 million in debt, giving a net cash position of -$22.97 million or -$0.17 per share.
| Cash & Cash Equivalents | 89.90M |
| Total Debt | 112.87M |
| Net Cash | -22.97M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 263.50M |
| Book Value Per Share | 1.99 |
| Working Capital | 148.47M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $21.92 million and capital expenditures -$13.41 million, giving a free cash flow of $8.52 million.
| Operating Cash Flow | 21.92M |
| Capital Expenditures | -13.41M |
| Free Cash Flow | 8.52M |
| FCF Per Share | $0.06 |
Full Cash Flow StatementMargins
Gross margin is 75.14%, with operating and profit margins of 3.09% and -3.69%.
| Gross Margin | 75.14% |
| Operating Margin | 3.09% |
| Pretax Margin | -2.91% |
| Profit Margin | -3.69% |
| EBITDA Margin | 6.69% |
| EBIT Margin | 3.09% |
| FCF Margin | 1.90% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.40% |
| Shareholder Yield | 0.40% |
| Earnings Yield | -4.17% |
| FCF Yield | 2.15% |
Analyst Forecast
The average price target for ORGO is $4.88, which is 63.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.88 |
| Price Target Difference | 63.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 4 |